11-118658345-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_007180.3(TREH):c.1696C>T(p.His566Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000384 in 1,600,052 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_007180.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TREH | ENST00000264029.9 | c.1696C>T | p.His566Tyr | missense_variant | 15/15 | 1 | NM_007180.3 | ENSP00000264029.5 | ||
TREH | ENST00000397925.2 | c.1603C>T | p.His535Tyr | missense_variant | 14/14 | 1 | ENSP00000381020.2 | |||
TREH | ENST00000613915.4 | n.*1473C>T | non_coding_transcript_exon_variant | 13/13 | 2 | ENSP00000477923.1 | ||||
TREH | ENST00000613915.4 | n.*1473C>T | 3_prime_UTR_variant | 13/13 | 2 | ENSP00000477923.1 |
Frequencies
GnomAD3 genomes AF: 0.000282 AC: 43AN: 152218Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000175 AC: 39AN: 223172Hom.: 0 AF XY: 0.000132 AC XY: 16AN XY: 121094
GnomAD4 exome AF: 0.000394 AC: 571AN: 1447716Hom.: 0 Cov.: 31 AF XY: 0.000366 AC XY: 263AN XY: 718824
GnomAD4 genome AF: 0.000282 AC: 43AN: 152336Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74498
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2022 | The c.1696C>T (p.H566Y) alteration is located in exon 15 (coding exon 15) of the TREH gene. This alteration results from a C to T substitution at nucleotide position 1696, causing the histidine (H) at amino acid position 566 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
TREH-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 04, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at